Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (22 quarters reported)
$248M in Q2 2013 → $2.24M now. Hover for any quarter.
As reported for the quarter ended September 30, 2018. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| AP Aveo Pharmaceuticals Inc | 100.0% | Unchanged | 675,242 | $2.24M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2018 · filed November 14, 2018
No position changes this quarter.
quarter ended June 30, 2018 · filed August 14, 2018
No position changes this quarter.
quarter ended March 31, 2018 · filed May 15, 2018
No position changes this quarter.
quarter ended December 31, 2017 · filed February 14, 2018
No position changes this quarter.
quarter ended September 30, 2017 · filed November 14, 2017
No position changes this quarter.
quarter ended June 30, 2017 · filed August 14, 2017
No position changes this quarter.
quarter ended March 31, 2017 · filed May 22, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| L Lifelock Inc | Exited | −5,540,485 | −$133M | — |
quarter ended December 31, 2016 · filed February 14, 2017
No position changes this quarter.
Loading...
